Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Esther, Llop"'
Autor:
Adrià Duran, Pedro E. Guerrero, Maria Rosa Ortiz, Dúnia Pérez del Campo, Ernesto Castro, Adelaida Garcia-Velasco, Esther Fort, Rafael de Llorens, Radka Saldova, Esther Llop, Rosa Peracaula
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 1942 (2022)
Currently, there are no reliable biomarkers for the diagnosis of pancreatic cancer (PaC). Glycoproteomic approaches that analyze the glycan determinants on specific glycoproteins have proven useful to develop more specific cancer biomarkers than the
Externí odkaz:
https://doaj.org/article/4f9c97c307a3403791b9747ea1669e8b
Autor:
Gordon Greville, Esther Llop, Chengnan Huang, Jack Creagh-Flynn, Stephanie Pfister, Roisin O'Flaherty, Stephen F. Madden, Rosa Peracaula, Pauline M. Rudd, Amanda McCann, Radka Saldova
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Glycosylation is one of the most fundamental post-translational modifications. Importantly, glycosylation is altered in many cancers. These alterations have been proven to impact on tumor progression and to promote tumor cell survival. Fr
Externí odkaz:
https://doaj.org/article/62c26e37f725440d8260bcfd53d09ea3
Autor:
Esther Llop, Ana Ardá, Elsa Zacco, Roisin O’Flaherty, María-Salud García-Ayllón, Massimo Aureli, Moran Frenkel-Pinter, Celso A. Reis, Ole K. Greiner-Tollersrud, Inmaculada Cuchillo-Ibáñez
Publikováno v:
Glycoconjugate Journal. 39:579-586
The Cost Action “Innovation with glycans: new frontiers from synthesis to new biological targets” (INNOGLY) hosted the Workshop “Neuroglycoproteins in health and disease”, in Alicante, Spain, on March 2022. This event brought together an euro
Autor:
Laura Miró, Júlia López, Pedro E. Guerrero, Neus Martínez-Bosch, Noemí Manero-Rupérez, Mireia Moreno, M. Rosa Ortiz, Esther Llop, Pilar Navarro, Rosa Peracaula
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6133
Hypersialylation is a feature of pancreatic ductal adenocarcinoma (PDA) and it has been related to tumor malignancy and immune suppression. In this work, we have evaluated the potential of the sialyltransferase inhibitor, Ac3FNeu5Ac, to decrease tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::453814240ad4f643f03aee29dacb0e41
http://hdl.handle.net/10261/304589
http://hdl.handle.net/10261/304589
Autor:
Laura, Miró, Júlia, López, Pedro E, Guerrero, Neus, Martínez-Bosch, Noemí, Manero-Rupérez, Mireia, Moreno, M Rosa, Ortiz, Esther, Llop, Pilar, Navarro, Rosa, Peracaula
Publikováno v:
Cancers. 14(24)
Hypersialylation is a feature of pancreatic ductal adenocarcinoma (PDA) and it has been related to tumor malignancy and immune suppression. In this work, we have evaluated the potential of the sialyltransferase inhibitor, Ac
Autor:
Esther, Llop, Rosa, Peracaula
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2370
Many clinical biomarkers in cancer are glycoproteins, but the majority of them only consider the protein levels. Indeed, only alfa-fetoprotein (AFP) in hepatocarcinoma and CA15-3 in breast cancer are clinically monitored for their glycoforms. Aberran
Autor:
Esther Llop, Rosa Peracaula
Publikováno v:
Glycosylation ISBN: 9781071616840
Many clinical biomarkers in cancer are glycoproteins, but the majority of them only consider the protein levels. Indeed, only alfa-fetoprotein (AFP) in hepatocarcinoma and CA15-3 in breast cancer are clinically monitored for their glycoforms. Aberran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84f1f40a4d8c0e1fffbb76056f0eb6ba
https://doi.org/10.1007/978-1-0716-1685-7_15
https://doi.org/10.1007/978-1-0716-1685-7_15
Autor:
Esther Llop Escorihuela, Marta Planas, Carles Rostán Sánchez, Joaquim Comas Matas, Marta Orts Alís, Ariadna Lleonart Sitjar, Anna Amadó Codony, Helena Benito Mundet
Publikováno v:
Redined, Red de Información Educativa
Ministerio de Educación, Cultura y Deporte (MECD)
Educación XX1, 2021, vol. 24, núm. 2, p. 65-96
Articles publicats (D-EM)
DUGiDocs – Universitat de Girona
instname
Ministerio de Educación, Cultura y Deporte (MECD)
Educación XX1, 2021, vol. 24, núm. 2, p. 65-96
Articles publicats (D-EM)
DUGiDocs – Universitat de Girona
instname
The commitment or academic implication (engagement) of university students has become a fundamental element for their welfare and academic performance and, furthermore, it is also related to their professional future and social commitment. For this r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0db0d00639d2891c5da203098f24d8
https://hdl.handle.net/11162/215697
https://hdl.handle.net/11162/215697
Autor:
Esther Llop, Pilar Navarro, Pedro Enrique Guerrero, Anna Massaguer, Laura Miró, Bin Sheng Wong, Neus Martínez-Bosch, Rosa Peracaula, Rafael de Llorens, Konstantinos Konstantopoulos
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 17
International Journal of Molecular Sciences, 2020, vol. 21, núm. 17, p. 6239
Articles publicats (D-B)
DUGiDocs – Universitat de Girona
instname
Digital.CSIC. Repositorio Institucional del CSIC
International Journal of Molecular Sciences, Vol 21, Iss 6239, p 6239 (2020)
Volume 21
Issue 17
International Journal of Molecular Sciences, 2020, vol. 21, núm. 17, p. 6239
Articles publicats (D-B)
DUGiDocs – Universitat de Girona
instname
Digital.CSIC. Repositorio Institucional del CSIC
International Journal of Molecular Sciences, Vol 21, Iss 6239, p 6239 (2020)
Aberrant sialylation is frequently found in pancreatic ductal adenocarcinoma (PDA). &alpha
2,3-Sialyltransferases (&alpha
2,3-STs) ST3GAL3 and ST3GAL4 are overexpressed in PDA tissues and are responsible for increased biosynthesis of sialyl
2,3-Sialyltransferases (&alpha
2,3-STs) ST3GAL3 and ST3GAL4 are overexpressed in PDA tissues and are responsible for increased biosynthesis of sialyl
Autor:
Pedro Enrique, Guerrero, Adrià, Duran, Maria Rosa, Ortiz, Ernesto, Castro, Adelaida, Garcia-Velasco, Esther, Llop, Rosa, Peracaula
Publikováno v:
Journal of proteomics. 231
Late diagnosis of pancreatic ductal adenocarcinoma (PDA) is one of the reasons of its low 5-year survival rate and it is due to its unspecific symptoms during the first stages of the disease and the lack of reliable serological markers. Since PDA sho